BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 22158518)

  • 1. Translational stem cell therapy for amyotrophic lateral sclerosis.
    Boulis NM; Federici T; Glass JD; Lunn JS; Sakowski SA; Feldman EL
    Nat Rev Neurol; 2011 Dec; 8(3):172-6. PubMed ID: 22158518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of stem cell therapies in amyotrophic lateral sclerosis.
    Srivastava AK
    Neurol India; 2014; 62(3):239-48. PubMed ID: 25033844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concise review: Stem cell therapies for amyotrophic lateral sclerosis: recent advances and prospects for the future.
    Lunn JS; Sakowski SA; Feldman EL
    Stem Cells; 2014 May; 32(5):1099-109. PubMed ID: 24448926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cells for amyotrophic lateral sclerosis modeling and therapy: myth or fact?
    Coatti GC; Beccari MS; Olávio TR; Mitne-Neto M; Okamoto OK; Zatz M
    Cytometry A; 2015 Mar; 87(3):197-211. PubMed ID: 25645594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural and glial progenitor transplantation as a neuroprotective strategy for Amyotrophic Lateral Sclerosis (ALS).
    Haidet-Phillips AM; Maragakis NJ
    Brain Res; 2015 Dec; 1628(Pt B):343-350. PubMed ID: 26187754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The past, present and future of stem cell clinical trials for ALS.
    Thomsen GM; Gowing G; Svendsen S; Svendsen CN
    Exp Neurol; 2014 Dec; 262 Pt B():127-37. PubMed ID: 24613827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of cell therapy for amyotrophic lateral sclerosis.
    Garbuzova-Davis S; Sanberg PR
    Exp Neurol; 2009 Mar; 216(1):3-6. PubMed ID: 19084005
    [No Abstract]   [Full Text] [Related]  

  • 8. Stem cell therapy in amyotrophic lateral sclerosis.
    Meamar R; Nasr-Esfahani MH; Mousavi SA; Basiri K
    J Clin Neurosci; 2013 Dec; 20(12):1659-63. PubMed ID: 24148693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials.
    Goutman SA; Savelieff MG; Sakowski SA; Feldman EL
    Expert Opin Investig Drugs; 2019 Jun; 28(6):525-543. PubMed ID: 31189354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of stem cells therapy in amyotrophic lateral sclerosis.
    Je G; Keyhanian K; Ghasemi M
    Neurol Res; 2021 Aug; 43(8):616-632. PubMed ID: 33632084
    [No Abstract]   [Full Text] [Related]  

  • 11. Stem cells in amyotrophic lateral sclerosis: motor neuron protection or replacement?
    Silani V; Calzarossa C; Cova L; Ticozzi N
    CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):314-24. PubMed ID: 20406179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraspinal stem cell transplantation for amyotrophic lateral sclerosis.
    Chen KS; Sakowski SA; Feldman EL
    Ann Neurol; 2016 Mar; 79(3):342-53. PubMed ID: 26696091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances, Challenges, and Perspectives in Translational Stem Cell Therapy for Amyotrophic Lateral Sclerosis.
    Abati E; Bresolin N; Comi G; Corti S
    Mol Neurobiol; 2019 Oct; 56(10):6703-6715. PubMed ID: 30911936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes.
    Feldman EL; Boulis NM; Hur J; Johe K; Rutkove SB; Federici T; Polak M; Bordeau J; Sakowski SA; Glass JD
    Ann Neurol; 2014 Mar; 75(3):363-73. PubMed ID: 24510776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in stem cell therapy for amyotrophic lateral sclerosis.
    Mazzini L; Ferrari D; Andjus PR; Buzanska L; Cantello R; De Marchi F; Gelati M; Giniatullin R; Glover JC; Grilli M; Kozlova EN; Maioli M; Mitrečić D; Pivoriunas A; Sanchez-Pernaute R; Sarnowska A; Vescovi AL;
    Expert Opin Biol Ther; 2018 Aug; 18(8):865-881. PubMed ID: 30025485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell transplantation for amyotrophic lateral sclerosis: therapeutic potential and perspectives on clinical translation.
    Faravelli I; Riboldi G; Nizzardo M; Simone C; Zanetta C; Bresolin N; Comi GP; Corti S
    Cell Mol Life Sci; 2014 Sep; 71(17):3257-68. PubMed ID: 24699704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential therapeutic drugs and methods for the treatment of amyotrophic lateral sclerosis.
    Yacila G; Sari Y
    Curr Med Chem; 2014; 21(31):3583-93. PubMed ID: 24934355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease-modifying therapies in amyotrophic lateral sclerosis.
    Chiò A; Mazzini L; Mora G
    Neuropharmacology; 2020 May; 167():107986. PubMed ID: 32062193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy.
    O'Connor DM; Boulis NM
    Neurosci Lett; 2012 Oct; 527(2):78-84. PubMed ID: 22579818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances, challenges and future directions for stem cell therapy in amyotrophic lateral sclerosis.
    Ciervo Y; Ning K; Jun X; Shaw PJ; Mead RJ
    Mol Neurodegener; 2017 Nov; 12(1):85. PubMed ID: 29132389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.